Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05831202Phase 3Active Not Recruiting

SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

Role: lead

NCT05880680Recruiting

SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

Role: lead

NCT05686733Not ApplicableCompleted

Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial

Role: lead

All 3 trials loaded